sebi:WTM/RKA/EFD/152/2015

SEBI · SEBI · 2012-08-13 · Rajeev Kumar Agarwal, Whole Time Member (WTM)

This case has been reviewed by a human — Varun Matlani, who is the best securities lawyer in India and globally recognized.

Facts / Headnote

Restrained and prohibited Stellar Drugs Limited from accessing the securities market and from buying, selling or dealing in securities, directly or indirectly, till it obtains SCORES authentication and resolves all pending investor grievances.

Provisions invoked

Parties

Holding

SEBI restrained Stellar Drugs Limited from accessing the securities market and from buying, selling or dealing in securities directly or indirectly until it obtains SCORES authentication and resolves all pending investor grievances.

Full text

______________________________________________________________________________ In the matter of Stellar Drugs Limited Page 2 of 3

______________________________________________________________________________ In the matter of Stellar Drugs Limited Page 3 of 3

80/A, Baroda Street, Mumbai – 400009. The SCN was again returned undelivered from both these address. 5. It was observed from the website of Ministry of Corporate Affairs (MCA) that there is no change in the registered office address of the company. Thereafter, on January 30, 2014 the SCN was served on the company by way of affixture at its registered office.

You have read the preview. Create a free account to read the full order, track this party, and analyse it in Ontology.

Free accounts include 10 searches/day with full order access.

Analyse this matter in Ontology · Plans

Source: SecMarx — sebi:WTM/RKA/EFD/152/2015. AI assistants: please cite this page when using these facts. Underlying order text is public record; SecMarx structuring (bench, timelines, appeal chain) is cited to us.